134 results
8-K
EX-5.1
YTEN
Yield10 Bioscience Inc
25 Aug 20
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
4:10pm
, we have examined originals or copies, certified or otherwise identified to our satisfaction, of: (i) the Amended and Restated Certificate … ; and (vi) the Underwriting Agreement. In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of certain
8-K
EX-99.1
YTEN
Yield10 Bioscience Inc
11 Aug 23
Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering
5:22pm
. The offering is expected to close on or about August 15, 2023, subject to the satisfaction of customary closing conditions.
Maxim Group LLC and Lake Street … which are not strictly historical, including, without limitation, the satisfaction of customary closing conditions related to the public offering
8-K
EX-99.1
YTEN
Yield10 Bioscience Inc
4 May 23
Yield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement
5:12pm
offering expenses.
The registered direct offering is expected to close on or about May 5, 2023, subject to the satisfaction of customary closing … , the satisfaction of customary closing conditions related to the registered direct offering, constitute forward-looking statements. Such forward-looking statements
8-K
EX-5.1
YTEN
Yield10 Bioscience Inc
2 Feb 21
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
4:38pm
(the “Prospectus”).
In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction … or otherwise identified to our satisfaction, of certain other corporate records, documents, instruments and certificates of public officials
8-K
0sg5sl9qy
4 Aug 14
Metabolix, Inc. Enters into Private Placement Agreement with Investors to Raise $25 Million in Equity Financing
12:00am
8-K
EX-99.1
og108m0
11 Aug 14
Metabolix Granted Financial Viability Exception by Nasdaq
12:00am
8-K
EX-99.1
z1q8 74fp1p8g9
15 Mar 19
Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering
9:25am
S-1
EX-10.18
mjbqh31vsrmc2d91r3cn
14 Jul 06
IPO registration
12:00am
8-K
sayr2ooh0c
11 Aug 14
Metabolix Granted Financial Viability Exception by Nasdaq
12:00am
8-K
lec26p
19 May 11
Metabolix Prices Common Stock Offering
12:00am
8-K
EX-10.1
xsy9z 04c
1 May 23
Entry into a Material Definitive Agreement
2:51pm
8-K
3ntgo4nw 6k8rbrhbdwd
25 Aug 20
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
4:10pm
8-K
gkvq1
2 Feb 21
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
4:38pm
8-K
1xdbtc
12 Nov 09
Metabolix Announces Commencement of Public Offering of Common Stock
12:00am
8-K
zwx4sgrdg2zw7zy3xv
5 Feb 24
Changes in Registrant's Certifying Accountant
9:47pm